CB2 has been shown to play a regulatory role in neuroinflammatory and neurodegenerative diseases such as Alzheimer’s disease (AD), Huntington’s disease (HD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). This evidence concerns the gene CNR2 and Parkinson disease.